Is it time to reconsider universal severe acute respiratory syndrome coronavirus 2 polymerase chain reaction screening for asymptomatic potential nonlung solid organ transplant donors?

Natori, Yoichiro; Anjan, Shweta; Hand, Jonathan

Natori, Yoichiro; Anjan, Shweta; Hand, Jonathan.

Affiliation

Natori Y; Miami Transplant Institute, Jackson Health System, Miami, Florida, USA; Department of Medicine, Division of Infectious Disease, University of Miami Miller School of Medicine Miami, Florida, USA. Electronic address: yxn138@med.miami.edu.
Anjan S; Miami Transplant Institute, Jackson Health System, Miami, Florida, USA; Department of Medicine, Division of Infectious Disease, University of Miami Miller School of Medicine Miami, Florida, USA.
Hand J; Ochsner Health, New Orleans, Louisiana, USA; Department of Medicine, Division of Infectious Disease, University of Queensland School of Meidcine, New Orleansm Louisiana, USA.

Am J Transplant ; 24(5): 879-880, 2024 May.

Article in En | MEDLINE | ID: mdl-38266710

Subject(s)

COVID-19; Organ Transplantation; SARS-CoV-2; Tissue Donors; Humans; COVID-19/epidemiology; COVID-19/diagnosis; COVID-19/prevention & control; Organ Transplantation/adverse effects; Tissue and Organ Procurement/methods; Mass Screening/methods; COVID-19 Nucleic Acid Testing/methods; Polymerase Chain Reaction/methods; Donor Selection/standards; Donor Selection/methods

Key words

SARS-CoV-2; adverse events; solid organ transplant; vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tissue Donors / Organ Transplantation / SARS-CoV-2 / COVID-19 Type of study: Diagnostic_studies / Screening_studies Limits: Humans Language: En Journal: Am J Transplant Journal subject: TRANSPLANTE Year: 2024 Type: Article

Fulltext

XML

PubMed Links

Search on Google